Rob Maloney: Over 104,000 USD Raised at The 2026 Trot to Clot
Rob Maloney, Chief Executive Officer of Hemophilia of Georgia, shared on LinkedIn:
”On May 16th, a small community did something remarkable.
Over 104,000 USD raised at the 2026 Trot to Clot.
I’ve said it before and I mean it every time.
It’s the big actions of a small community that make this work possible.
Every dollar raised goes toward our global impact program.
People living with bleeding disorders in underserved communities around the world who don’t have what our patients in Georgia have.
Access, support, a team that knows their name.
That gap is real. And events like this help close it.
To our sponsors, thank you. You make the starting line possible.
To our team captains, fundraisers, runners, walkers, volunteers, and donors.
You showed up. That matters more than you know.
This community never stops surprising me.
If you couldn’t make it this year but want to be part of what we’re building globally, there’s still a way in.
See you at the finish line next year.”
Stay updated with Hemostasis Today.
-
Jun 9, 2026, 10:02Understanding Factor X Deficiency – ICHCC
-
Jun 9, 2026, 09:49Lee Severin: Why Patients Love Platelet-Rich Plasma
-
Jun 9, 2026, 09:42Lorena Gerlach: Blood Transportation Duty on this Muggy Spring Day
-
Jun 9, 2026, 08:54Shujha Abbas: Understanding the Real Cost of Gene Therapie
-
Jun 9, 2026, 04:47Akshat Jain: Marstacimab Gets FDA Expension for Children with Hemophilia B
-
Jun 9, 2026, 03:30Fayad Al-Haimus: High-Risk Emergencies and Lifelong Learning at CAEP 2026
-
Jun 9, 2026, 03:14Rucha Patil: A Collaborative Initiative to Transform Rare Blood Disorder Care in Rajasthan
-
Jun 9, 2026, 02:28Andreas Calatzis: Chasing Biologically Inactive Heparin?
-
Jun 9, 2026, 02:16Javier Lagos Servellon: Reflections on Completing the University of Bern’s Stroke Medicine Program